Ajanta Pharma Revenue
Pharmaceutical Manufacturing • 
Borivali, Maharashtra, India • 5001-10000 Employees
Ajanta Pharma revenue & valuation
| Annual revenue | $490,700,000 |
| Revenue per employee | $59,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $1,570,100,000 |
| Total funding | No funding |
Key Contacts at Ajanta Pharma
Puneet Kapur
Country Director For Kazakhstan &Kyrgyzstan
Sanjay Nautiyal
Head Of Sales
Abdhesh Gupta
Head Of Sales And Business Development
Kranti Acharekar
Art Director
Amol Dhavane
Advisor Director
Anjan Mallik
Owner
Chintan Makwana
Owner
Chaitanya Deshpande
Business Owner
Boop Ahaha
Non Executive Director
Ratnesh Kumar Mishra
Owner
Company overview
| Headquarters | 98 Ajanta House, Charkop, Kandivili West, Mumbai, Maharashtra 400067, IN |
| Phone number | +912266061000 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Generics, Complex Formulations, Speciality Branded Generics |
| Founded | 1973 |
| Employees | 5001-10000 |
| Socials |
Ajanta Pharma Email Formats
Ajanta Pharma uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@ajantapharma.com), used 67.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@ajantapharma.com | 67.4% |
{first initial}.{last name} | j.doe@ajantapharma.com | 31.3% |
About Ajanta Pharma
Ajanta Pharma Limited is a pharmaceutical company headquartered in Mumbai, India. It has strong presence in Branded Generic business in India & Emerging markets; and Generic business in USA. In India, company operates in selected therapeutic areas of Cardiology, Dermatology, Ophthalmology, and Pain management. Recently Ajanta also got into two new promising therapies of Nephrology and Gynaecology. Its brands hold leadership positions in sub-therapeutic areas they are present in. In Emerging Markets, company has presence in Africa, South East Asia, West Asia, and CIS on broader therapeutic segments such as antimalarial, gastro, antibiotics, cardiology, dermatology, pain management, etc. As on 31st Mar 2025, Ajanta has 47 ANDA approvals which are commercialised. It holds 2 tentative approvals and 22 ANDAs are awaiting US FDA approval. Company plans to file 8-12 ANDAs every year. Company has state-of-the-art research facilities for formulation and API development located at Mumbai, India. R&D capabilities are evident from number of 1st to market products launched by the company providing patients most needed compliance and convenience. A dedicated and focused team of over 850 scientists work for R&D, which is growing continuously. Ajanta has 6 formulations manufacturing facilities located in India. Besides that, it also has an API manufacturing facility located at Waluj, India. Ajanta’s flagship formulation facilities at Paithan (Maharashtra, India) and Dahej (Gujarat, India) have been approved by US FDA. Ajanta continuously invests in enhancing the existing manufacturing facilities to meet current cGMP requirements and also construct new facilities to meet company’s growth requirements. Please visit https://ajantapharma.com/ for more information.
Employees by Management Level
Total employees: 5001-10000
Seniority
Employees
Employees by Department
Ajanta Pharma has 3,207 employees across 20 departments.
Departments
Number of employees
Funding Data
Ajanta Pharma has never raised funding before.
Ajanta Pharma Tech Stack
Discover the technologies and tools that power Ajanta Pharma's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Security
Web frameworks
JavaScript libraries
Tag managers
Webmail
Programming languages
Font scripts
UI frameworks
SSL/TLS certificate authorities
JavaScript libraries
Australia
Frequently asked questions
4.8
40,000 users
